COYA (STOCKS)
Coya Therapeutics, Inc. Common Stock
$4.890000
+0.150000 (+3.16%)
Prev close: $4.740000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Arun Swaminathan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $114.82M
- Employees
- 8
- P/E (TTM)
- -4.52
- P/B (TTM)
- 2.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.32 | $-0.42 | +0.1016 | +24.10% |
|
Dec 2025 (Q4)
|
$-0.34 | $-0.28 | -0.0617 | -22.17% |
|
Sep 2025 (Q3)
|
$-0.13 | $-0.28 | +0.1488 | +53.37% |
|
Jun 2025 (Q2)
|
$-0.36 | $-0.40 | +0.0407 | +10.16% |
Financial Statements
| Assets | $53.27M |
| Current Assets | $53.26M |
| Noncurrent Assets | $8.42K |
| Fixed Assets | $8.42K |
| Liabilities | $4.30M |
| Current Liabilities | $3.55M |
| Accounts Payable | $948.19K |
| Other Current Liabilities | $2.60M |
| Noncurrent Liabilities | $754.20K |
| Equity | $48.97M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $48.97M |
| Liabilities And Equity | $53.27M |